Strides Pharma Science Shows Strong Performance Amid Broader Market Gains

Strides Pharma Science has experienced a notable increase of 5.27% on May 5, 2025, outperforming the broader market sector by 4.23%. The stock reached an intraday high of Rs 667.75, reflecting a rise of 4.92% during the trading session. Currently, Strides Pharma is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong short-term performance relative to its historical trends.
In the context of the overall market, the Sensex has shown positive momentum, climbing 206.54 points to reach 80,868.16, a gain of 0.45%. The BSE Mid Cap index is leading the market with a 1.4% increase, contributing to a three-week consecutive rise for the Sensex, which has gained 7.6% over this period.

Over the past year, Strides Pharma Science has delivered an impressive performance, with a 57.90% increase compared to the Sensex's 9.45%. However, its three-month performance shows a decline of 9.38%, contrasting with the Sensex's gain of 3.31%. Overall, Strides Pharma Science continues to demonstrate resilience in the mid-cap pharmaceuticals sector.